| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18442 R78278 |
Lee (Controls exposed to TCAs), 2025 | 1-minute Apgar score <7 | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: SSRI only |
0.89 [0.59;1.36] C excluded (control group) |
73/1,465 34/613 | 107 | 1,465 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18408 R77700 |
Lee (Controls unexposed, general pop), 2025 | 1-minute Apgar score <7 | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 1.41 [1.09;1.82] | 73/1,465 14,883/463,440 | 14,956 | 1,465 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S14995 R61358 |
Lyn, 2023 | 1 min Apgar score of less than seven | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 2.11 [0.97;4.58] | -/130 -/259 | - | 130 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7569 R22725 |
Hogue, 2017 | 1-minute Apgar score less than 7 (in full-term neonates) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 3.60 [1.06;12.50] | 15/117 6/116 | 21 | 117 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S13007 R49379 |
Bakaysa, 2016 | Low APGAR scores at 1 minute (< 7) | late pregnancy | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 2.00 [1.10;3.50] | 27/112 32/224 | 59 | 112 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7570 R22764 |
Kivistö, 2016 | Low (<7) Apgar score at 1 min | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 2.29 [1.65;3.18] | 51/358 1,451/24,402 | 1,502 | 358 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5408 R16601 |
Wisner (Controls unexposed, disease free), 2009 | Apgar Score ≤7 at 1 minute | throughout pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: no or not specified |
1.33 [0.53;3.32] C excluded (control group) |
8/48 17/130 | 25 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6249 R16609 |
Wisner (Controls unexposed, sick), 2009 | Apgar Score ≤7 at 1 minute | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 0.73 [0.17;3.24] C | 8/48 3/14 | 11 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 6 studies | 1.84 [1.38;2.46] | 16,549 | 2,230 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, general pop; 2: Controls unexposed, sick;
Asymetry test p-value = 0.6541 (by Egger's regression)
slope=0.4581 (0.2472); intercept=0.5260 (1.0884); t=0.4833; p=0.6541
excluded 5408, 18442